BioCentury
ARTICLE | Company News

Boston Heart Diagnostics sales and marketing update

June 4, 2012 7:00 AM UTC

Boston Heart Diagnostics launched its Statin Induced Myopathy (SLCO1B1) Genotype test in the U.S. to identify patients at higher risk for developing severe myopathy as a side effect of statins. The t...